Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208850500> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3208850500 abstract "Background: A new sweetener with the commercial name of Lacritose has been recently produced, which is a combination of four simple sugars (lactose, fructose, sucrose, erythritol), with specific ingredients and percentages. This study aimed to assess glycemic response and short term gastrointestinal reactions in type 2 diabetic patients.
 Methods: In this triple-blind randomized clinical trial, 30 diabetic patients referred to Yazd Diabetes Research Center in 2018 were included. After collecting the primary data, they were assigned into three groups, including sucrose consumers as the control group, sucrose-lactose, and lacritose as the groups of consumers group. They were followed for two weeks, and fasting blood glucose (FBG), 2-hour postprandial test (2HPP), fructose amine, SGOT, SGPT, urea, creatinine, and insulin resistance index (HOMA-IR) were assessed.
 Results: In lacritose consumers, significant reductions were seen in FBG and 2HPP (P < 0.001 and P = 0.05, respectively), although changes among the groups were not significant. In sucrose-lacritose consumers, FBG and cholesterol levels decreased (P = 0.04 and P = 0.03, respectively). In sucrose consumers, no reduction was seen. HOMA-IR did not significantly decrease, but intergroup changes were obvious.
 Conclusion: The lacritose effects on FBG and 2HPP were significantly evident, but the other metabolic indices did not show any significant change." @default.
- W3208850500 created "2021-11-08" @default.
- W3208850500 creator A5022782152 @default.
- W3208850500 creator A5040827457 @default.
- W3208850500 creator A5042335990 @default.
- W3208850500 creator A5057932659 @default.
- W3208850500 creator A5086245086 @default.
- W3208850500 date "2021-10-30" @default.
- W3208850500 modified "2023-09-27" @default.
- W3208850500 title "The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial" @default.
- W3208850500 doi "https://doi.org/10.18502/jnfs.v6i4.7620" @default.
- W3208850500 hasPublicationYear "2021" @default.
- W3208850500 type Work @default.
- W3208850500 sameAs 3208850500 @default.
- W3208850500 citedByCount "0" @default.
- W3208850500 crossrefType "journal-article" @default.
- W3208850500 hasAuthorship W3208850500A5022782152 @default.
- W3208850500 hasAuthorship W3208850500A5040827457 @default.
- W3208850500 hasAuthorship W3208850500A5042335990 @default.
- W3208850500 hasAuthorship W3208850500A5057932659 @default.
- W3208850500 hasAuthorship W3208850500A5086245086 @default.
- W3208850500 hasBestOaLocation W32088505001 @default.
- W3208850500 hasConcept C126322002 @default.
- W3208850500 hasConcept C134018914 @default.
- W3208850500 hasConcept C185592680 @default.
- W3208850500 hasConcept C2776652674 @default.
- W3208850500 hasConcept C2776970464 @default.
- W3208850500 hasConcept C2777108408 @default.
- W3208850500 hasConcept C2777180221 @default.
- W3208850500 hasConcept C2777391703 @default.
- W3208850500 hasConcept C2778199505 @default.
- W3208850500 hasConcept C2778597767 @default.
- W3208850500 hasConcept C2778724459 @default.
- W3208850500 hasConcept C2779306644 @default.
- W3208850500 hasConcept C2780473172 @default.
- W3208850500 hasConcept C2780485761 @default.
- W3208850500 hasConcept C31903555 @default.
- W3208850500 hasConcept C555293320 @default.
- W3208850500 hasConcept C71924100 @default.
- W3208850500 hasConceptScore W3208850500C126322002 @default.
- W3208850500 hasConceptScore W3208850500C134018914 @default.
- W3208850500 hasConceptScore W3208850500C185592680 @default.
- W3208850500 hasConceptScore W3208850500C2776652674 @default.
- W3208850500 hasConceptScore W3208850500C2776970464 @default.
- W3208850500 hasConceptScore W3208850500C2777108408 @default.
- W3208850500 hasConceptScore W3208850500C2777180221 @default.
- W3208850500 hasConceptScore W3208850500C2777391703 @default.
- W3208850500 hasConceptScore W3208850500C2778199505 @default.
- W3208850500 hasConceptScore W3208850500C2778597767 @default.
- W3208850500 hasConceptScore W3208850500C2778724459 @default.
- W3208850500 hasConceptScore W3208850500C2779306644 @default.
- W3208850500 hasConceptScore W3208850500C2780473172 @default.
- W3208850500 hasConceptScore W3208850500C2780485761 @default.
- W3208850500 hasConceptScore W3208850500C31903555 @default.
- W3208850500 hasConceptScore W3208850500C555293320 @default.
- W3208850500 hasConceptScore W3208850500C71924100 @default.
- W3208850500 hasLocation W32088505001 @default.
- W3208850500 hasLocation W32088505002 @default.
- W3208850500 hasOpenAccess W3208850500 @default.
- W3208850500 hasPrimaryLocation W32088505001 @default.
- W3208850500 hasRelatedWork W1990456597 @default.
- W3208850500 hasRelatedWork W2048908145 @default.
- W3208850500 hasRelatedWork W2069423225 @default.
- W3208850500 hasRelatedWork W2264852224 @default.
- W3208850500 hasRelatedWork W2328161519 @default.
- W3208850500 hasRelatedWork W2795573272 @default.
- W3208850500 hasRelatedWork W2927423482 @default.
- W3208850500 hasRelatedWork W2979772551 @default.
- W3208850500 hasRelatedWork W3109301515 @default.
- W3208850500 hasRelatedWork W745381067 @default.
- W3208850500 isParatext "false" @default.
- W3208850500 isRetracted "false" @default.
- W3208850500 magId "3208850500" @default.
- W3208850500 workType "article" @default.